Eton Pharmaceuticals (ETON) Raw Materials (2024 - 2026)
Eton Pharmaceuticals (ETON) posted Raw Materials of $557000.0 for Q4 2025, down 89.6% sequentially from $5.4 million in Q4 2024, and down 89.6% YoY from $5.4 million in Q4 2024.
Eton Pharmaceuticals (ETON) Raw Materials (2024 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Raw Materials for 2 years, with the latest figure at $557000.0 in Q4 2025.
- Quarterly Raw Materials fell 89.6% year-over-year to $557000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $557000.0 (down 89.6% YoY) and the FY2025 annual result came in at $557000.0, down 89.6% from the prior year.
- Raw Materials fell to $557000.0 in Q4 2025 per ETON's latest filing, from $5.4 million in the prior quarter.
- Over five years, Raw Materials peaked at $5.4 million in Q4 2024 and troughed at $557000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 690,000.00 |
| Dec 31, 2025 | 557,000.00 |
| Dec 31, 2024 | 5.36 Mn |